Registry for patients with end-stage renal disease in Lorraine
French Renal Epidemiology and Information Network (REIN) Registry in Lorraine
Central Hospital, Nancy, France · NCT03967808
This study is collecting information from patients with end-stage kidney disease in Lorraine to help improve their treatment and care.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 6000 (estimated) |
| Sex | All |
| Sponsor | Central Hospital, Nancy, France (other) |
| Locations | 1 site (Nancy) |
| Trial ID | NCT03967808 on ClinicalTrials.gov |
What this trial studies
The REIN Registry aims to improve the prevention and management of end-stage renal disease by collecting comprehensive data on patients undergoing renal replacement therapy in the Lorraine area. It includes all patients starting renal replacement therapy, documenting key events such as renal transplantation and changes in dialysis settings. The registry is supported by a network of nephrologists and public health representatives, ensuring accurate and complete data collection through regular verification visits to dialysis centers. This initiative promotes clinical and epidemiological research to enhance patient outcomes.
Who should consider this trial
Good fit: Ideal candidates for this registry are patients diagnosed with end-stage renal disease who are undergoing renal replacement therapy.
Not a fit: Patients with acute renal failure who recover renal function within 45 days or those who refuse participation may not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could lead to improved management strategies and outcomes for patients with end-stage renal disease.
How similar studies have performed: Other registries focusing on renal disease management have shown success in improving patient outcomes and informing health strategies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients with end stage renal disease on renal replacement therapy Exclusion Criteria: * Patients with acute renal failure ( i.e. those who recover all or some renal function within 45 days or are considered as such by experts when they die before 45 days) * Patient's refusal
Where this trial is running
Nancy
- Nephrology unit, University hospital — Nancy, France (RECRUITING)
Study contacts
- Principal investigator: Emmanuelle Laurain, MD — Central Hospital, Nancy, France
- Study coordinator: Carole Ayav, MD
- Email: c.ayav@chru-nancy.fr
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: End-stage Renal Disease, Registry, Renal replacement therapy